An endorsement of PCSK9 inhibitors funded by … their manufacturers

    loading  Checking for direct PDF access through Ovid

Abstract

How objective were consensus panel recommendations for use of expensive PCKS9 inhibitors in patients who experience side effects with statins? Nigel Hawkes reports on industry links

Related Topics

    loading  Loading Related Articles